SNY logo

Sanofi (SNY) Net income

annual net income:

$6.02B+$171.77M(+2.94%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY annual net profit is $6.02 billion, with the most recent change of +$171.77 million (+2.94%) on December 1, 2024.
  • During the last 3 years, SNY annual net income has fallen by -$1.35 billion (-18.27%).
  • SNY annual net income is now -57.14% below its all-time high of $14.04 billion, reached on December 31, 2020.

Performance

SNY Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

quarterly net income:

$531.91M-$2.56B(-82.82%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY quarterly net profit is $531.91 million, with the most recent change of -$2.56 billion (-82.82%) on December 1, 2024.
  • Over the past year, SNY quarterly net income has stayed the same.
  • SNY quarterly net income is now -93.64% below its all-time high of $8.37 billion, reached on June 30, 2020.

Performance

SNY quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

TTM net income:

$6.06B+$1.13B(+22.92%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY TTM net profit is $6.06 billion, with the most recent change of +$1.13 billion (+22.92%) on December 1, 2024.
  • Over the past year, SNY TTM net income has stayed the same.
  • SNY TTM net income is now -50.03% below its all-time high of $12.12 billion, reached on June 30, 2020.

Performance

SNY TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SNY Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.9%0.0%0.0%
3 y3 years-18.3%-76.4%-21.7%
5 y5 years+95.2%-76.4%-21.7%

SNY Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-31.8%+2.9%-83.3%+189.0%-37.1%+32.2%
5 y5-year-57.1%+95.2%-93.6%+189.0%-50.0%+81.8%
alltimeall time-57.1%+804.2%-93.6%+118.4%-50.0%+753.0%

Sanofi Net income History

DateAnnualQuarterlyTTM
Dec 2024
$6.02B(+2.9%)
$531.91M(-82.8%)
$6.06B(+22.9%)
Sep 2024
-
$3.10B(+158.3%)
$4.93B(+7.6%)
Jun 2024
-
$1.20B(-2.6%)
$4.58B(-7.4%)
Mar 2024
-
$1.23B(-305.9%)
$4.95B(-15.6%)
Dec 2023
$5.85B(-33.8%)
-$597.68M(-121.7%)
$5.86B(-39.2%)
Sep 2023
-
$2.75B(+75.7%)
$9.64B(+7.3%)
Jun 2023
-
$1.56B(-27.0%)
$8.98B(+3.6%)
Mar 2023
-
$2.14B(-32.6%)
$8.67B(-1.3%)
Dec 2022
$8.83B(+19.9%)
$3.18B(+52.1%)
$8.78B(+27.0%)
Sep 2022
-
$2.09B(+67.1%)
$6.91B(-8.4%)
Jun 2022
-
$1.25B(-44.5%)
$7.54B(-2.5%)
Mar 2022
-
$2.25B(+71.5%)
$7.74B(+5.0%)
Dec 2021
$7.36B(-47.6%)
$1.31B(-51.8%)
$7.37B(+21.7%)
Sep 2021
-
$2.72B(+88.6%)
$6.05B(+81.8%)
Jun 2021
-
$1.44B(-23.5%)
$3.33B(-67.5%)
Mar 2021
-
$1.89B(-77.4%)
$10.25B(-15.4%)
Dec 2020
$14.04B(+355.4%)
-
-
Jun 2020
-
$8.37B(+350.5%)
$12.12B(+231.6%)
Mar 2020
-
$1.86B(-2805.2%)
$3.65B(+18.3%)
Dec 2019
$3.08B(-39.4%)
-$68.65M(-103.5%)
$3.09B(-10.4%)
Sep 2019
-
$1.96B(-2109.1%)
$3.45B(-16.5%)
Jun 2019
-
-$97.74M(-107.6%)
$4.13B(-19.6%)
Mar 2019
-
$1.29B(+345.7%)
$5.14B(+0.9%)
Dec 2018
$5.08B(-46.7%)
$289.80M(-89.0%)
$5.09B(+3.2%)
Sep 2018
-
$2.64B(+190.6%)
$4.93B(+19.4%)
Jun 2018
-
$909.85M(-27.1%)
$4.13B(-5.3%)
Mar 2018
-
$1.25B(+854.9%)
$4.36B(-52.5%)
Dec 2017
$9.53B(+82.9%)
$130.71M(-92.9%)
$9.19B(-7.3%)
Sep 2017
-
$1.84B(+61.5%)
$9.91B(-0.3%)
Jun 2017
-
$1.14B(-81.2%)
$9.93B(-1.7%)
Mar 2017
-
$6.07B(+612.6%)
$10.10B(+93.2%)
Dec 2016
$5.21B(+9.6%)
$852.26M(-54.4%)
$5.23B(+10.3%)
Sep 2016
-
$1.87B(+42.8%)
$4.74B(+1.3%)
Jun 2016
-
$1.31B(+9.1%)
$4.68B(-2.7%)
Mar 2016
-
$1.20B(+228.1%)
$4.81B(+0.9%)
Dec 2015
$4.76B(-18.5%)
$365.44M(-79.8%)
$4.77B(-21.5%)
Sep 2015
-
$1.81B(+25.7%)
$6.07B(+4.0%)
Jun 2015
-
$1.44B(+24.7%)
$5.84B(+6.8%)
Mar 2015
-
$1.15B(-31.0%)
$5.47B(-5.7%)
Dec 2014
$5.84B(+18.3%)
$1.67B(+6.0%)
$5.80B(+4.1%)
Sep 2014
-
$1.58B(+48.0%)
$5.57B(-0.7%)
Jun 2014
-
$1.07B(-28.2%)
$5.61B(+9.4%)
Mar 2014
-
$1.49B(+2.9%)
$5.13B(+3.6%)
Dec 2013
$4.94B
$1.44B(-10.7%)
$4.95B(+23.5%)
Sep 2013
-
$1.62B(+176.1%)
$4.01B(-7.1%)
Jun 2013
-
$585.15M(-55.2%)
$4.32B(-17.2%)
DateAnnualQuarterlyTTM
Mar 2013
-
$1.31B(+160.1%)
$5.21B(-17.0%)
Dec 2012
$6.28B(-20.2%)
$502.01M(-73.9%)
$6.28B(-17.9%)
Sep 2012
-
$1.92B(+30.0%)
$7.65B(-11.0%)
Jun 2012
-
$1.48B(-37.6%)
$8.60B(+0.4%)
Mar 2012
-
$2.37B(+26.5%)
$8.57B(+9.0%)
Dec 2011
$7.87B(+8.6%)
$1.88B(-34.6%)
$7.86B(+19.5%)
Sep 2011
-
$2.87B(+97.9%)
$6.58B(+13.7%)
Jun 2011
-
$1.45B(-13.0%)
$5.79B(-11.1%)
Mar 2011
-
$1.67B(+180.8%)
$6.51B(-9.8%)
Dec 2010
$7.25B(-1.3%)
$593.28M(-71.5%)
$7.22B(-14.2%)
Sep 2010
-
$2.08B(-4.4%)
$8.41B(+0.6%)
Jun 2010
-
$2.17B(-8.4%)
$8.36B(+9.6%)
Mar 2010
-
$2.37B(+32.9%)
$7.63B(+4.2%)
Dec 2009
$7.34B(+29.9%)
$1.79B(-12.1%)
$7.32B(+106.0%)
Sep 2009
-
$2.03B(+40.6%)
$3.55B(-18.3%)
Jun 2009
-
$1.44B(-30.0%)
$4.35B(-8.1%)
Mar 2009
-
$2.06B(-204.0%)
$4.73B(+7.1%)
Dec 2008
$5.65B(-21.7%)
-$1.98B(-170.1%)
$4.42B(-46.6%)
Sep 2008
-
$2.83B(+54.7%)
$8.28B(+14.4%)
Jun 2008
-
$1.83B(+4.5%)
$7.24B(+0.4%)
Mar 2008
-
$1.75B(-7.1%)
$7.21B(+0.0%)
Dec 2007
$7.22B(+43.3%)
$1.88B(+5.3%)
$7.21B(+13.0%)
Sep 2007
-
$1.79B(-0.6%)
$6.38B(+13.4%)
Jun 2007
-
$1.80B(+2.9%)
$5.63B(+14.3%)
Mar 2007
-
$1.75B(+65.9%)
$4.93B(-1.4%)
Dec 2006
$5.03B(+79.3%)
$1.05B(+1.8%)
$5.00B(+11.4%)
Sep 2006
-
$1.03B(-5.4%)
$4.49B(+3.8%)
Jun 2006
-
$1.09B(-39.9%)
$4.33B(+10.5%)
Mar 2006
-
$1.82B(+235.8%)
$3.91B(-0.9%)
Dec 2005
$2.81B(+13.8%)
$541.62M(-37.8%)
$3.95B(-48.1%)
Sep 2005
-
$871.40M(+27.6%)
$7.61B(+97.7%)
Jun 2005
-
$682.92M(-63.2%)
$3.85B(+0.3%)
Mar 2005
-
$1.86B(-55.8%)
$3.84B(+42.6%)
Dec 2004
$2.47B(+5.2%)
$4.20B(-245.3%)
$2.69B(-390.0%)
Sep 2004
-
-$2.89B(-530.9%)
-$927.49M(-134.4%)
Jun 2004
-
$670.44M(-5.5%)
$2.70B(+5.3%)
Mar 2004
-
$709.64M(+22.0%)
$2.56B(+8.7%)
Dec 2003
$2.35B(+40.9%)
$581.61M(-21.0%)
$2.36B(+5.2%)
Sep 2003
-
$736.67M(+37.5%)
$2.24B(+14.4%)
Jun 2003
-
$535.83M(+6.2%)
$1.96B(+8.5%)
Mar 2003
-
$504.76M(+8.4%)
$1.81B(+38.8%)
Dec 2002
$1.66B(+17.3%)
$465.76M(+2.6%)
$1.30B(+55.7%)
Sep 2002
-
$453.97M(+18.9%)
$835.77M(+118.9%)
Jun 2002
-
$381.80M
$381.80M
Dec 2001
$1.42B(+56.0%)
-
-
Dec 2000
$910.08M(+36.7%)
-
-
Dec 1999
$665.57M
-
-

FAQ

  • What is Sanofi annual net profit?
  • What is the all time high annual net income for Sanofi?
  • What is Sanofi annual net income year-on-year change?
  • What is Sanofi quarterly net profit?
  • What is the all time high quarterly net income for Sanofi?
  • What is Sanofi quarterly net income year-on-year change?
  • What is Sanofi TTM net profit?
  • What is the all time high TTM net income for Sanofi?
  • What is Sanofi TTM net income year-on-year change?

What is Sanofi annual net profit?

The current annual net income of SNY is $6.02B

What is the all time high annual net income for Sanofi?

Sanofi all-time high annual net profit is $14.04B

What is Sanofi annual net income year-on-year change?

Over the past year, SNY annual net profit has changed by +$171.77M (+2.94%)

What is Sanofi quarterly net profit?

The current quarterly net income of SNY is $531.91M

What is the all time high quarterly net income for Sanofi?

Sanofi all-time high quarterly net profit is $8.37B

What is Sanofi quarterly net income year-on-year change?

Over the past year, SNY quarterly net profit has changed by $0.00 (0.00%)

What is Sanofi TTM net profit?

The current TTM net income of SNY is $6.06B

What is the all time high TTM net income for Sanofi?

Sanofi all-time high TTM net profit is $12.12B

What is Sanofi TTM net income year-on-year change?

Over the past year, SNY TTM net profit has changed by $0.00 (0.00%)
On this page